FDA Investigator Lata C Mathew, PhD

Lata C Mathew, PhD has conducted inspections on 84 sites in 9 countries as of 23 Oct 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
84
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, Germany, Israel, Korea (Republic of), Switzerland, Japan, Spain, Italy
FDA Investigators that have inspected at least one site in common with Lata C Mathew, PhD:
Ademola O Daramola, Adetutu M Gidado, Alan P Kurtzberg, Albert M Brindle, Alberto A Viciedo, Alexandra B Pitkin, Alice S Tsao, Allen Lou, Amatul H Marium, Amber D Brodas, Amir Alavi, Amy L Singer, Angela E Glenn, Anissa M Vargas, Anita Narula, PhD, Anitha Palamakula Govada, Ankur C Patel, Anna M Alexander, Annemarie Bodnar, Annet R Rajan, Anthony C Taube, Anthony J Donato, Anthony M Criscuolo, Jr, Antoinette L Ravelli, Antonina Aydanian, Arduino Frankovic, Ariel Cruz Figueroa, Arindam Dasgupta, PhD, Arsen Karapetyan, Ashley N Queen, PhD, Azza Talaat, Barbara J Maulfair, Barbara Jwilimczyk Macri, Benton M Ketron, Bernice F Hirsch, Bijoy Panicker, Binh T Nguyen, Bonita S Chester, Brian P Putz, Byungja E Marciante, Cara M Minelli, Carl A Huffman, III, Carrie A Hughes, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, Chaoying C Ma, Charanjeet Jassal, Charles J Chacko, Charles Jewell, Charles M Edwards, Charlotte P Chang, Cheryl A Clausen, Cheryl A Grandinetti, Christina N Maurino, Christopher R Czajka, Concepcion Cruz, Jr, Constantin Y Philopoulos, Daniel J Grabicki, Daniel J Lahar, Daniel J Min, Daniel J Roberts, Daniel L Obrzut, Daniel L Zheng, David A Oluwo, David G Whitman, Deborah A Greco, Deborah B Goffman, Deborah B Nixon, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Deyaa Shaheen, Dhaval H Patel, Diane L Raccasi, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Don H Bark, PhD, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Carmelo Rosa, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Edward O'shaughnessy, Edwin Martinez, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric M Mueller, PharmD, Eric Rothschild, Erika V Butler, Erin D Mccaffery, Esther C Broner, PhD, Farhana Khan, Felix Maldonado, Frederick F Razzaghi, Freyja V Lynn, Gajendiran Mahadevan, PhD, Gam S Zamil, Gavin T Cua, George Pyramides, Gianine E Delade, Gianine E Tompkins, Grace Deneke, Gregson A Joseph, Guerlain Ulysse, Gwyn G Dickinson, Haitao Li, Hang N Guo, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Iram R Hassan, PhD, Ivy E Sweeney, Jacob G Lutz, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James C Maclaughlin, James M Mason, James R Birkenstamm, James S Cartwright, Janet A Rajan, Jason F Chancey, Jason K Morgan, Javier E Santos, Jay B Shah, Jazmine N Brown, Jean M Kelahan, Jeffery B Medwid, PhD, Jeffrey P Raimondi, Jennifer L Bridgewater, Jennifer M Gogley, Jennifer Macmillan, Jenny Sung, Jessica M Monteiro, Jessica S Estriplet, Jill Mielziner, Joan A Loreng, Joanne M Schlossin, Joey V Quitania, Jogy George, John P Mistler, Jonee J Mearns, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose R Hernandez, Joseph F Mcginnis, RPh, Joy P Matthias, Joy Rkozlowski Klena, Junho Pak, Justin A Boyd, Justine Tomasso, Karen A Spencer, Karen E D'orazio, Karen L Kosar, Karishma G Gopaul, Kassa Ayalew, MD, Katherine E Jacobitz, Katherine Szestypalow, Kathleen B Swat, Keith M Reilly, Kelli F Dobilas, Kellia N Hicks, Kelly Doremus, Kelly I Anderson, Kerun Hardeo, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Ko U Min, Krishnaiah Yellela, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Latorie S Jones, Lauren L Vajo, Laurimer Kuilan Torres, Lawrence R Johnson, Lestine C Webb, Li Li, Liatte Kreuger, PharmD, Liming Zhang, Linda F Murphy, Linda Thai, Lisa Harlan, Lori J Silverstein, Lori Peters, Luella J Rossi, Luis A Dasta, Luis Mburgos Medero, Maan S Abduldayem, Makini Cobourne Duval, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcus A Ray, Marcus F Yambot, Margaret M Annes, Margaret M Sands, Maria Estrella, Maria Joselopez Barragan, PhD, Maria Manzoni, PhD, Marie F Morin, Marjorie A Shapiro, PhD, Mark R Mcclain, Marsha W Major, Marshalette O Edwards, Martha T Olone, Mary Davis Lopez, Mary R Kirker, Massoud Motamed, Mate Tolnay, Matthew A Spataro, Matthew B Casale, Matthew J Johnson, Mayar M Mussa, Meisha R Sampson, Meisha Waters, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael A Taylor, Michael F Skelly, PhD, Michael L Chasey, Michael P Sheehan, Michael R Goga, Michael R Klapal, Michael Rosner, Michael S Araneta, Michael Serrano, Michael Shanks, MS, Michael T Cyrus, Miguel Gmanzano Maldonado, Mihaly S Ligmond, Milan S Blake, Mindy M Chou, Minh D Phan, Mohsen Rajabi Abhari, FDA, Monika Borkowska, Mra Davism, Muna Algharibeh, Muralidhara B Gavini, PhD, Nancy E Byerly, Nancy F Scheraga, Nancy M Espinal, Nancy T Waites, Nayan J Patel, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Nicholas L Hunt, Nicole E Knowlton, Niketa Patel, Nina Yang, Norman K Starks, Odera I Ekwunife, Omotunde O Osunsanmi, Pal S Mayasandra, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul E Stein, Paul L Bellamy, Paul Mouris, Paula A Trost, Perry T Nichols, Peter E Baker, Peter R Lenahan, Prabhu P Raju, Pratik S Upadhyay, DDC, Puspa Suresh Jayasekara, Rajiv R Srivastava, Raymond L Cheung, Raymond T Oji, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Remache, Richard D Manney, Richard H Penta, Richard W Thornton, Richmond K Yip, Rita K Kabaso, Robert J Doyle, Robert J Ham, Robert J Martin, Robert Jennings, Robert M Barbosa, Robin P Mathew, Rochelle L Cross, Rodney T Allnutt, Roger F Zabinski, Rose Ljean Mary, Rose Xu, Ross J Grigsby, Rumany C Penn, PharmD, Russell J Glapion, Saleem A Akhtar, Sam H Haidar, PhD, Samantha J Bradley, Samina S Khan, Sandra A Boyd, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Santos E Camara, Sarah Adella Fave, Sarah B Tanksley, Sarah E Mcmullen, Sarah M Meng, Sarah M Napier, Satheesh Thomas, Sayyem H Akbar, Schultz, Scott E Norris, Sena G Dissmeyer, Shahla Parvizi, Sharon K Thoma, PharmD, Sherri J Liu, Sherry G Bous, Shirley S Wen, Simone E Pitts, Sinai I Davis, Sony Mathews, Srinivas R Chennamaneni, PhD, Stacie A Woods, Stephanie T Durso, Stephen J Mottola, Stephenie M Ortiz, Steven A Brettler, Steven D Kehoe, Steven M Weinman, Steven P Donald, Suchan Kim, Susan D Yuscius, Susan F Laska, MS, Susan M Halsted, Susan M Jackson, Taichun Qin, PhD, Tanya R Syffrard, Tara G Bizjak, Tara K Carmody, Tara R Gooen, Teresa I Navas, Thomas J Arista, Thomas R Beilke, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tina S Roecklein, Tonia F Bernard, Toyin B Oladimeji, Tracey L Harris, Travis R Hunt, Tressa T Lewis, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie C Reed, Valerie Reed, Vickie L Anderson, Victoria Spivak, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Vivin George, Walden H Lee, Wayne E Seifert, Wayne J Meyer, William A Warnick, William J Leonard, William J Muszynski, William R Chang, William V Millar, Xikui Chen (nmi), PhD, Yi Wang, PhD, Yong Wu, PhD, Yoriann M Cabrera Bartolomei, Yvesna C Blaise, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zakaria I Ganiyu, Zedong Dong, Zhao Wang, PhD, Zhongren Wu

Lata C Mathew, PhD's Documents

Publish Date Document Type Title
November, 2020 FDA 483 Novel Laboratories, Inc. - Form 483, 2020-11-05
November, 2017 FDA 483 VASUDHA PHARMA CHEM LIMITED - Form 483, 2017-11-30
November, 2021 FDA 483 STIRA PHARMACEUTICALS LLC - Form 483, 2021-11-05
June, 2019 EIR ScieGen Pharmaceuticals INC - EIR, 2019-06-21
April, 2022 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2022-04-13
June, 2021 EIR Professional Disposables International, Inc. - EIR, 2021-07-30
June, 2017 FDA 483 MSN Life Sciences Private Limited - Form 483, 2017-06-30
October, 2017 EIR DERMARITE INDUSTRIES, LLC - EIR, 2017-10-30
April, 2019 FDA 483 Torrent Pharmaceuticals Limited - Form 483, 2019-04-16
April, 2021 EIR Gateway Analytical - EIR, 2021-04-14
September, 2022 FDA 483 Response Syenz Laboratory, LLC - Form 483R, 2022-09-30
May, 2018 FDA 483 Recipharm Pharmaservices Pvt. Ltd. - Form 483, 2018-05-11
October, 2023 FDA 483 Shionogi Pharma Co., Ltd. - Form 483, 2023-10-20
February, 2020 FDA 483 Aurolife Pharma LLC - Form 483, 2020-02-12
August, 2018 EIR Vertice Pharma Management Corp - EIR, 2018-08-29
January, 2020 EIR Sharp Mint Limited - EIR, 2020-01-31
April, 2017 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2017-04-06
February, 2022 FDA 483 Aspire Pharmaceuticals Inc. - Form 483, 2022-02-03
August, 2017 EIR SGS North America Inc. - EIR, 2017-08-30
November, 2020 FDA 483 Response Novel Laboratories, Inc. - Form 483R, 2020-11-05
September, 2021 FDA 483 International Trading Pharm Lab Inc - Form 483, 2021-09-16
June, 2022 FDA 483 MSN Life Sciences Private Limited - Form 483, 2022-06-03
January, 2023 FDA 483 ZENARA PHARMA PRIVATE LIMITED - Form 483, 2023-01-20
April, 2017 EIR Ajinomoto Althea, Inc. - EIR, 2017-04-06
October, 2017 FDA 483 DERMARITE INDUSTRIES, LLC - Form 483, 2017-10-30
July, 2019 FDA 483 PAB Organics Private Limited - Form 483, 2019-07-13
June, 2021 FDA 483 Response Professional Disposables International, Inc. - Form 483R, 2021-06-23
November, 2022 FDA 483 Hetero Labs Limited - Form 483, 2022-11-08
February, 2019 FDA 483 LUPIN LIMITED - Form 483, 2019-02-08
February, 2023 FDA 483 Invitron Advanced Analytics Private Limited - Form 483, 2023-02-02
February, 2019 FDA 483 CTX Lifesciences Pvt. Ltd. - Form 483, 2019-02-16
September, 2019 EIR CURIA NEW JERSEY LLC - EIR, 2019-09-16
June, 2019 EIR LTS Lohmann Therapy Systems Corp. - EIR, 2019-06-11
December, 2018 FDA 483 Novel Laboratories, Inc. - Form 483, 2018-12-21
October, 2019 EIR BCN Peptides SA - EIR, 2019-10-18
February, 2018 FDA 483 Vista Pharmaceuticals Limited - Form 483, 2018-02-09
October, 2023 FDA 483 Kaneka Corporation Takasago Plant - Form 483, 2023-10-13
October, 2023 FDA 483 SUMITOMO OSAKA CEMENT CO., LTD. - Form 483, 2023-10-27
January, 2020 FDA 483 Sharp Mint Limited - Form 483, 2020-01-31
November, 2022 FDA 483 Apitoria Pharma Private Limited - Form 483, 2022-11-18
June, 2023 FDA 483 Aucta Pharmaceuticals, Inc. - Form 483, 2023-06-07
June, 2021 FDA 483 Professional Disposables International, Inc. - Form 483, 2021-06-23
October, 2019 FDA 483 Laboratorios Liconsa SAU - Form 483, 2019-10-25
April, 2018 FDA 483 RIJ Pharmaceutical LLC - Form 483, 2018-04-13
September, 2022 FDA 483 Syenz Laboratory, LLC - Form 483, 2022-09-30
November, 2021 EIR STIRA PHARMACEUTICALS LLC - EIR, 2021-11-22
March, 2020 EIR APPCO PHARMA LLC - EIR, 2020-03-27
November, 2017 EIR Macleods Pharmaceuticals Limited - EIR, 2017-11-24
June, 2017 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2017-06-16
June, 2019 FDA 483 LTS Lohmann Therapy Systems Corp. - Form 483, 2019-06-11
December, 2019 EIR CorePharma, LLC - EIR, 2019-12-13
July, 2023 FDA 483 ST Pharm Co., Ltd. - Form 483, 2023-07-14
July, 2023 FDA 483 KOLMAR KOREA CO., LTD Gwanjeong 2 branch - Form 483, 2023-07-21
July, 2023 FDA 483 K.S.PEARL CO., LTD. - Form 483, 2023-07-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more